日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Case Report: Pyoderma gangrenosum masquerading as skin and soft tissue infection preceding myelodysplastic syndrome

病例报告：坏疽性脓皮病伪装成皮肤和软组织感染，先于骨髓增生异常综合征发生

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2026.1792269
Shi, Yan; Tang, Bo; Qu, Tao; Yu, Shuangni; Feng, Jun; Chang, Xiao; Wang, Xiaoting
炎症/感染
发表日期：2026
文献求助 收藏

Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception

胰腺腺鳞癌鳞状细胞转化过程中免疫监视功能的减弱，为癌症阻断治疗提供了新的契机。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012066
Chen, Xinyuan; Sun, Shanyue; Li, Shuofeng; Yu, Shuangni; Chen, Jie; Chen, Xianlong
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Tumor-stroma ratio combined with PD-L1 identifies pancreatic ductal adenocarcinoma patients at risk for lymph node metastases

肿瘤间质比值联合PD-L1可识别有淋巴结转移风险的胰腺导管腺癌患者

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03019-z
Chen, Xianlong; Sun, Shanyue; Zhao, Jiapeng; Yu, Shuangni; Chen, Jie; Chen, Xinyuan
PD-L1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A 16-year-old female with an intrasellar mass

一名16岁女性，患有鞍内肿块。

期刊:Brain Pathology
影响因子:6.2
doi:10.1111/bpa.70002
Xiao, Yinbo; Yin, Can; Lu, Junliang; Yu, Shuangni; Huo, Zhen; Liang, Zhiyong
发表日期：2025
文献求助 收藏

Pathological and clinical insights into DICER1 hotspot mutated Sertoli-Leydig cell tumors: a comparative analysis

DICER1热点突变型塞托利-莱迪格细胞瘤的病理学和临床见解：一项比较分析

期刊:Diagnostic Pathology
影响因子:2.3
doi:10.1186/s13000-025-01657-8
Lyu, Zhuoyao; Liu, Yilin; Chen, Jingci; Wang, Pengyan; Lu, Zhaohui; Chang, Xiaoyan; Chen, Xianlong; Ma, Heng; Mo, Shengwei; Yu, Shuangni; Chen, Jie
细胞生物学
DICER
发表日期：2025
文献求助 收藏

Malignant mesothelioma with a novel BAP1 germline frameshift mutation treated with dual immune checkpoint inhibitors: A case report

采用双重免疫检查点抑制剂治疗伴有新型BAP1种系移码突变的恶性间皮瘤：病例报告

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2025.15104
Zhou, Na; Wu, Mingying; Wang, Chenyu; Yuan, Mingming; Cheng, Yuejuan; Wu, Huanwen; Gao, Xin; Yu, Shuangni; Zhao, Lin
BAP1
免疫/内分泌
发表日期：2025
文献求助 收藏

Perioperative tislelizumab with four cycles of neoadjuvant chemotherapy for resectable locally advanced esophageal squamous cell carcinoma: a phase 2 study

围手术期替雷利珠单抗联合四周期新辅助化疗治疗可切除局部晚期食管鳞状细胞癌：一项 II 期研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1482005
Zhou, Na; Hua, Yuwei; Ge, Yuping; Wang, Qiang; Wang, Chenyu; He, Jia; Zhao, Luo; Yu, Shuangni; Yan, Junfang; Zhao, Lin; Li, Li; Bai, Chunmei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Analysis of PD-L1 promoter methylation combined with immunogenic context in pancreatic ductal adenocarcinoma

胰腺导管腺癌中PD-L1启动子甲基化与免疫原性背景的分析

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03745-y
Chen, Xinyuan; Yu, Shuangni; Chen, Jie; Chen, Xianlong
肿瘤
表观遗传
肿瘤免疫
PD-L1
免疫/内分泌
发表日期：2024
文献求助 收藏

Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas

将分子分型纳入高级别子宫内膜癌患者生存风险分层评估

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm12020530
Zong, Liju; Mo, Shengwei; Sun, Zezheng; Lu, Zhaohui; Chen, Jie; Yu, Shuangni; Xiang, Yang
子宫内膜癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review

利妥昔单抗联合白蛋白紫杉醇和顺铂成功治疗滤泡性淋巴瘤合并三阴性乳腺癌：病例报告及文献综述

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S430273
Zhu, Zhou; Zhou, Na; Yu, Shuangni; Gao, Xin; Cheng, Xin; Wang, Yingyi; Bai, Chunmei
肿瘤
淋巴瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏